Literature DB >> 21401260

Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.

Jason Rupp1, Mario Dzemidzic, Tanya Blekher, Veronique Bragulat, John West, Jacqueline Jackson, Siu Hui, Joanne Wojcieszek, Andrew J Saykin, David Kareken, Tatiana Foroud.   

Abstract

OBJECTIVE: Individuals with the trinucleotide CAG expansion (CAG+) that causes Huntington's disease (HD) have impaired performance on antisaccade (AS) tasks that require directing gaze in the mirror opposite direction of visual targets. This study aimed to identify the neural substrates underlying altered antisaccadic performance.
METHOD: Three groups of participants were recruited: (1) Imminent and early manifest HD (early HD, n = 8); (2) premanifest (presymptomatic) CAG+ (preHD, n = 10); and (3) CAG unexpanded (CAG-) controls (n = 12). All participants completed a uniform study visit that included a neurological evaluation, neuropsychological battery, molecular testing, and functional MRI during an AS task. The blood oxygenation level dependent (BOLD) response was obtained during saccade preparation and saccade execution for both correct and incorrect responses using regression analysis.
RESULTS: Significant group differences in BOLD response were observed when comparing incorrect AS to correct AS execution. Specifically, as the percentage of incorrect AS increased, BOLD responses in the CAG- group decreased progressively in a well-documented reward detection network that includes the presupplementary motor area and dorsal anterior cingulate cortex. In contrast, AS errors in the preHD and early HD groups lacked this relationship with BOLD signal in the error detection network, and BOLD responses to AS errors were smaller in the two CAG+ groups as compared with the CAG- group.
CONCLUSIONS: These results are the first to suggest that abnormalities in an error-related response network may underlie early changes in AS eye movements in premanifest and early manifest HD. (PsycINFO Database Record (c) 2011 APA, all rights reserved).

Entities:  

Mesh:

Year:  2011        PMID: 21401260      PMCID: PMC3086952          DOI: 10.1037/a0021873

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  110 in total

1.  The role of the ventrolateral frontal cortex in inhibitory oculomotor control.

Authors:  Tim Hodgson; Marcia Chamberlain; Benjamin Parris; Martin James; Nicholas Gutowski; Masud Husain; Christopher Kennard
Journal:  Brain       Date:  2007-04-23       Impact factor: 13.501

2.  Frontoparietal activation with preparation for antisaccades.

Authors:  Matthew R G Brown; Tutis Vilis; Stefan Everling
Journal:  J Neurophysiol       Date:  2007-06-27       Impact factor: 2.714

3.  Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.

Authors:  Robert Christian Wolf; Nenad Vasic; Carlos Schönfeldt-Lecuona; G Bernhard Landwehrmeyer; Daniel Ecker
Journal:  Brain       Date:  2007-09-13       Impact factor: 13.501

4.  Increased cortical recruitment in Huntington's disease using a Simon task.

Authors:  Nellie Georgiou-Karistianis; Anusha Sritharan; Maree Farrow; Ross Cunnington; Julie Stout; John Bradshaw; Andrew Churchyard; Tamara-Leigh Brawn; Phyllis Chua; Edmond Chiu; Dhananjay Thiruvady; Gary Egan
Journal:  Neuropsychologia       Date:  2007-01-18       Impact factor: 3.139

Review 5.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

6.  An effect of context on saccade-related behavior and brain activity.

Authors:  Kara A Dyckman; Jazmin Camchong; Brett A Clementz; Jennifer E McDowell
Journal:  Neuroimage       Date:  2007-03-28       Impact factor: 6.556

7.  Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.

Authors:  Marie-Noëlle W Witjes-Ané; Bart Mertens; Jeroen P P van Vugt; Anne-Catherine Bachoud-Lévi; Gert-Jan B van Ommen; Raymund A C Roos
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

8.  Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

Authors:  Kevin Duff; Jane S Paulsen; Leigh J Beglinger; Douglas R Langbehn; Julie C Stout
Journal:  Biol Psychiatry       Date:  2007-05-03       Impact factor: 13.382

9.  Saccadometry: a new tool for evaluating presymptomatic Huntington patients.

Authors:  Chrystalina A Antoniades; Pat M E Altham; Sarah L Mason; Roger A Barker; Roger Carpenter
Journal:  Neuroreport       Date:  2007-07-16       Impact factor: 1.837

10.  fMRI detection of early neural dysfunction in preclinical Huntington's disease.

Authors:  Janice L Zimbelman; Jane S Paulsen; Ania Mikos; Norman C Reynolds; Raymond G Hoffmann; Stephen M Rao
Journal:  J Int Neuropsychol Soc       Date:  2007-09       Impact factor: 2.892

View more
  4 in total

Review 1.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 2.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

Review 3.  The diagnostic value of saccades in movement disorder patients: a practical guide and review.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Janet C Rucker; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2015-10-15

Review 4.  Quantifying Motor Impairment in Movement Disorders.

Authors:  James J FitzGerald; Zhongjiao Lu; Prem Jareonsettasin; Chrystalina A Antoniades
Journal:  Front Neurosci       Date:  2018-04-11       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.